Cambridge Life Sciences Limited
Private Limited Company · Ely
ActiveUnited KingdomIncorporated 2003Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
Accounts to 2025-06-30
IXBRL · 160 source facts · 28 selected values
Validation findingsXBRL valid
Accounts to 2025-06-30
IXBRL · 160 source facts · 28 selected values
Validation findings
XBRL valid
- Reporting period
- 2024-07-01 to 2025-06-30
- Extraction status
- complete
- Numeric facts
- 87
- Documents processed
- 1
- XBRL standards validation
- valid
- Filing-profile validation
- invalid
- Parser
- arelle 2.44.4
- Taxonomy
- FRS-102-2025-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2603_04897864_20250630
- Source archive
- Accounts_Monthly_Data-March2026.zip
Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.
Accounts to 2024-06-30
IXBRL · 301 source facts · 36 selected values
Validation findingsXBRL valid
Accounts to 2024-06-30
IXBRL · 301 source facts · 36 selected values
Validation findings
XBRL valid
- Reporting period
- 2023-07-01 to 2024-06-30
- Extraction status
- complete
- Numeric facts
- 209
- Documents processed
- 1
- XBRL standards validation
- valid
- Filing-profile validation
- invalid
- Parser
- arelle 2.44.4
- Taxonomy
- FRS-102-2023-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2506_04897864_20240630
- Source archive
- Accounts_Monthly_Data-June2025.zip
Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.
Accounts to 2023-06-30
IXBRL · 316 source facts · 35 selected values
Not assessedlegacy record
Accounts to 2023-06-30
IXBRL · 316 source facts · 35 selected values
Not assessed
legacy record
- Reporting period
- 2022-07-01 to 2023-06-30
- Extraction status
- Legacy / not assessed
- Numeric facts
- 222
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- secr-frs-102-2021-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_1866_04897864_20230630
- Source archive
- Accounts_Monthly_Data-March2024.zip
Accounts to 2022-06-30
IXBRL · 321 source facts · 37 selected values
Not assessedlegacy record
Accounts to 2022-06-30
IXBRL · 321 source facts · 37 selected values
Not assessed
legacy record
- Reporting period
- 2021-07-01 to 2022-06-30
- Extraction status
- Legacy / not assessed
- Numeric facts
- 231
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2019-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0018_04897864_20220630
- Source archive
- Accounts_Monthly_Data-June2023.zip
Accounts to 2021-06-30
IXBRL · 342 source facts · 36 selected values
Not assessedlegacy record
Accounts to 2021-06-30
IXBRL · 342 source facts · 36 selected values
Not assessed
legacy record
- Reporting period
- 2020-01-01 to 2021-06-30
- Extraction status
- Legacy / not assessed
- Numeric facts
- 248
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2019-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0104_04897864_20210630
- Source archive
- Accounts_Monthly_Data-March2022.zip
Registered details
04897864- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 2003-09-12
- Jurisdiction
- —
- Registered office
- 14 ST THOMAS PLACE, ELY, CAMBRIDGESHIRE, CB7 4EX
Classification
1 SIC codes23006
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
0 SH01-derived roundsNo reconstructed allotment rounds.
Research and innovation
3 matched grantsi-sense: EPSRC IRC in Agile Early Warning Sensing Systems for Infectious Diseases and Antimicrobial ResistanceEPSRC · Research Grant · 2018-09-30 – 2024-03-31 · with 31 other participants£4,300,619whole project
i-sense: EPSRC IRC in Agile Early Warning Sensing Systems for Infectious Diseases and Antimicrobial Resistance
EPSRC · Research Grant · 2018-09-30 – 2024-03-31 · with 31 other participants
£4,300,619
whole project
University College LondonleadAdámas NanoAfrica Health Research InstituteCambridge Life Sciences LtdCharité - University of Medicine BerlinCuebiqDiagnostic Evidence Cooperative LondonÉcole Polytechnique de MontréalGoogleGoogle UK LimitedImperial College LondonIxscient ltdJohns Hopkins UniversityLondon School of Hygiene and Tropical Medicine (LSHTM)Microsoft ResearchMicrosoft Research LimitedMologic LtdNatural History MuseumNewcastle UniversityNewcastle Upon Tyne Hospitals NHS Foundation TrustO2 Telefonica Europe plcOxford Nanopore TechnologiesOxford Nanopore Technologies PLCPublic Health EnglandRMIT UniversityRoyal College of General PractitionersThe Francis Crick InstituteUclaUCL Hospitals NHS Foundation TrustUniversity of California, Los Angeles (UCLA)University Of OxfordUniversity of Surrey
IRC Next Steps Plus: Ultra-Sensitive Enhanced NanoSensing of Anti-Microbial Resistance (u-Sense).EPSRC · Research Grant · 2018-09-30 – 2024-03-31 · with 6 other participants£1,388,114whole project
IRC Next Steps Plus: Ultra-Sensitive Enhanced NanoSensing of Anti-Microbial Resistance (u-Sense).
EPSRC · Research Grant · 2018-09-30 – 2024-03-31 · with 6 other participants
£1,388,114
whole project
Newcastle UniversityleadAlbert Einstein College of MedicineCambridge Life Sciences LtdIxscient ltdNewcastle UniversityNewcastle Upon Tyne Hospitals NHS Foundation TrustPublic Health England
EPSRC IRC in Early-Warning Sensing Systems for Infectious DiseasesEPSRC · Research Grant · 2013-09-30 – 2020-03-30 · with 57 other participants£11,057,928whole project
EPSRC IRC in Early-Warning Sensing Systems for Infectious Diseases
EPSRC · Research Grant · 2013-09-30 – 2020-03-30 · with 57 other participants
£11,057,928
whole project
University College LondonleadAdámas NanoAfrica Health Research InstituteBangor UniversityBecton, Dickinson and CompanyBruker CorporationCambridge Immunosensors LtdCambridge Life Sciences LtdCentre for Sexual Health and HIV AIDS Research Zimbabwe (CeSHHAR Zimbabwe)Engineering and Physical Sciences Research Council (EPSRC)Faculty ScienceFoundation for Innovative New Diagnostics (FIND)Francis Crick InstituteGoogleGreat Ormond Street Hospital (GOSH)Guy's HospitalImperial College LondonInnovate UKInstitute of Tropical Medicine AntwerpInstitute of Tropical Medicine " Pedro Kouri "iXscientJohn Innes CentreLaboratory of the Government Chemist (LGC) LtdLondon School of Hygiene and Tropical Medicine (LSHTM)Massachusetts Institute of TechnologyMerieux FoundationmicrodropMicrosoft ResearchMicrosoft Research LimitedMologicMologic LtdNational Institute for Health and Care Excellence (NICE)National Institute for Health and Care ResearchNewcastle UniversityNewcastle Upon Tyne Hospitals NHS Foundation TrustO2 Telefonica Europe plcOJ-Bio LtdOxford Nanopore TechnologiesPasteur Institute, ParisPlanairPublic Health EnglandQvq B.V.Roche PharmaceuticalsRoyal College of General PractitionersRoyal Institute of TechnologySwiss Federal Institute of Technology in Lausanne (EPFL)Swiss Tropical & Public Health InstituteTwistDxUganda Virus Research InstituteUK Sepsis TrustUmea UniversityUniversity College HospitalUniversity of California, Los Angeles (UCLA)University of North Carolina HospitalsUniversity of StrathclydeUniversity of SurreyUS ArmyZurich Instruments AG